TTD_Target_ID	Target_Name	TTD_Drug_ID	Drug_Name	Drug_Highest_Status	Drug_PubchemID	Molecular_Formula	Molecular_Weight	Canonical_SMILES	Activity	Binder_Type
T89213	Neuropeptide Y receptor type 1	B0J6NT	2-Biphenyl-4-yl-N-[4-guanidino-1-(1,3,4,5-tetrahydro-benzo[c]azepine-2-carbonyl)-butyl]-acetamide	Investigative	44287829	C30H35N5O2	497.6	C1CC2=CC=CC=C2CN(C1)C(=O)C(CCCN=C(N)N)NC(=O)CC3=CC=C(C=C3)C4=CC=CC=C4	IC50 = 76000 nM	Poor binder
T89213	Neuropeptide Y receptor type 1	B1J3XG	{3-[2-(4-Dimethylamino-piperidin-1-yl)-ethyl]-benzo[b]thiophen-2-yl}-methanol	Investigative	44362839	C18H26N2OS	318.5	CN(C)C1CCN(CC1)CCC2=C(SC3=CC=CC=C32)CO	Ki = 88000 nM	Poor binder
T89213	Neuropeptide Y receptor type 1	B1JY5V	2-(6-((4,5-Dimethyloxazol-2-ylthio)methyl)-4-morpholinopyridin-2-ylamino)acetonitrile	Investigative	44229546	C17H21N5O2S	359.4	CC1=C(OC(=N1)SCC2=NC(=CC(=C2)N3CCOCC3)NCC#N)C	IC50 = 70000 nM	Poor binder
T89213	Neuropeptide Y receptor type 1	B96KXR	2-[1-(4-Amino-6,7-dimethoxy-quinazolin-2-yl)-piperidin-4-yl]-2,3-dihydro-isoindol-1-one	Investigative	20556258	C23H25N5O3	419.5	COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCC(CC3)N4CC5=CC=CC=C5C4=O)N)OC	IC50 = 60000 nM	Poor binder
T89213	Neuropeptide Y receptor type 1	BA4LZ2	N-[4-Guanidino-1-(1,3,4,5-tetrahydro-benzo[c]azepine-2-carbonyl)-butyl]-2,2,2-triphenyl-acetamide	Investigative	44288236	C36H39N5O2	573.7	C1CC2=CC=CC=C2CN(C1)C(=O)C(CCCN=C(N)N)NC(=O)C(C3=CC=CC=C3)(C4=CC=CC=C4)C5=CC=CC=C5	IC50 = 51000 nM	Poor binder
T89213	Neuropeptide Y receptor type 1	BX6W3Y	2-(4-Chlorophenoxymethyl)-1-(2-piperidinoethyl)-1H-benzimidazole	Investigative	10809141	C21H24ClN3O	369.9	C1CCN(CC1)CCN2C3=CC=CC=C3N=C2COC4=CC=C(C=C4)Cl	Ki ~ 100000 nM	Poor binder